GlassScriptPhysician profile
Vincent M Lubrano
NPI 1285683219
$1,712.71
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $140 · 2021: $526 · 2022: $745 · 2023: $79.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.39.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $290.96 | 2020-2022 | |
| Abbvie INC. | $194.57 | 2019-2023 | |
| Channel Medsystems, INC. | $115.27 | 2022 | |
| Daiichi Sankyo INC. | $114.84 | 2019-2022 | |
| Astellas Pharma US INC | $114.77 | 2022 | |
| Therapeuticsmd, INC. | $106.93 | 2019-2022 | |
| Hologic Sales and Service, LLC | $104.51 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $88.38 | 2021-2022 | |
| Myovant Sciences INC. | $84.59 | 2021-2022 | |
| Exeltis, USA INC. | $77.08 | 2021-2023 | Slynd |
| Gynesonics, INC. | $71.92 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Mayne Pharma Commercial LLC | $69.53 | 2021-2022 | |
| Aspira Women'S Health INC | $58.21 | 2021 | |
| Pfizer INC. | $50.03 | 2022-2023 | |
| Agile Therapeutics, INC. | $27.56 | 2021-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $27.01 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.93 | 2021-2022 | |
| Lupin INC. | $23.17 | 2021 | |
| Abbott Laboratories | $21.58 | 2022 | |
| Meditrina | $19.48 | 2022 | |
| Coopersurgical, INC. | $13.45 | 2022 | |
| Ferring Pharmaceuticals INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincent Lubrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.